Lung Cancer in People’s Republic of China

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.5K citations · Full text

Medicine, Oncology, Radiation Oncology +15

Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement

Virginia A. Moyer · Annals of Internal Medicine · 2013 · 2.6K citations

Medicine, Oncology, Preventive Medicine +17

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

Yuankai Shi, Joseph S. K. Au, Sumitra Thongprasert et al. · Journal of Thoracic Oncology · 2014 · 1.6K citations · Full text

Medicine, Genetics, Oncology +14

The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer

Feng‐Hua Wang, Lin Shen, Jin Li et al. · Cancer Communications · 2019 · 856 citations · Full text

Medicine, Oncology, Gastroenterology +8

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

Wen‐Zhao Zhong, Qun Wang, Weimin Mao et al. · The Lancet Oncology · 2017 · 529 citations

Medicine, Oncology, Pharmacology +10